Nymox Pharmaceutical
NYMX
#10117
Rank
S$23.36 M
Marketcap
Country
S$0.26
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Total assets
Total assets on the balance sheet as of June 2023 : S$0.34 Million
According to Nymox Pharmaceutical's latest financial reports the company's total assets are S$0.34 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Nymox Pharmaceutical - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | S$2.17 M | 11.67% |
| 2021-12-31 | S$1.95 M | -66.05% |
| 2020-12-31 | S$5.74 M | -22.36% |
| 2019-12-31 | S$7.4 M | -32.93% |
| 2018-12-31 | S$11.03 M | 742.59% |
| 2017-12-31 | S$1.3 M | -56.02% |
| 2016-12-31 | S$2.97 M | 195.54% |
| 2015-12-31 | S$1 M | -46.4% |
| 2014-12-31 | S$1.87 M | 53.52% |
| 2013-12-31 | S$1.22 M | -42.92% |
| 2012-12-31 | S$2.14 M | -74.02% |
| 2011-12-31 | S$8.25 M | -52.53% |
| 2010-12-31 | S$17.39 M | 1036.13% |
| 2009-12-31 | S$1.53 M | -73.68% |
| 2008-12-31 | S$5.81 M | -5.11% |
| 2007-12-31 | S$6.13 M | 0.69% |
| 2006-12-31 | S$6.08 M | -1.67% |
| 2005-12-31 | S$6.19 M | -6.65% |
| 2004-12-31 | S$6.63 M | -5.3% |
| 2003-12-31 | S$7 M | -7.39% |
| 2002-12-31 | S$7.56 M | -2.55% |
| 2001-12-31 | S$7.76 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | S$104.24 B | 30,054,512.55% | 🇺🇸 USA |
 Pfizer PFE | S$266.25 B | 76,762,999.63% | 🇺🇸 USA |
 Quest Diagnostics
DGX | S$20.21 B | 5,829,051.29% | 🇺🇸 USA |
 Eli Lilly LLY | S$114.40 B | 32,984,697.05% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$247.87 B | 71,465,213.65% | 🇺🇸 USA |